Regulatory Disclosures

Business Continuity Plan

Edgemont Capital Partners, L.P. (“EDGE”), pursuant to Financial Industry Regulatory Authority, Inc. (“FINRA”) rules, has created a Business Continuity Plan, to address and guide our response to and recovery from Significant Business Disruptions (“SBDs”). Copies of this Summary Disclosure Statement shall be given to all clients at the time they open their accounts with EDGE. EDGE’s Business Continuity Plan is subject to modification and an updated summary will be promptly sent to our clients. Alternatively, clients may obtain updated summaries by requesting a written copy by mail or fax.

In all of the following scenarios, EDGE plans to continue business and our planned recovery time, depending upon the time of occurrence, should not exceed 24 hours from the time of the declaration of the SBD. Staff, telephone calls, and e-mails will return to their original location upon full restoration of service.

Disruption to a single building or our Firm’s main office:

If a disruption occurs at our main office located at 787 7th Avenue, 49th Floor, New York, NY 10019, the firm shall continue to operate from residential office locations.

Disruption to a business district:

If a disruption occurs in our business district affecting our main office, the firm shall continue to operate from residential office locations. If possible, these locations shall be outside the business district.

City-wide business disruption:

If a disruption occurs in our city-wide area that affects our main office, the firm shall continue to operate from residential office locations. If possible, these locations shall be outside the city-wide area.

Regional disruption:

If a regional disruption occurs that affects our main office, the firm shall continue to operate from residential office locations. If possible, these locations shall be outside the regional area.

Please call if you should have any questions at (212) 867-8935.

Member SIPC

You may obtain information about the Securities Investor Protection Corporation (SIPC), including a copy of the SIPC brochure, by calling them at (202) 371-8300 or visiting their web site at sipc.org.

Anti-Money Laundering

Edgemont Capital Partners, L.P. (“EDGE”) is committed to complying with U.S. statutory and regulatory requirements designed to combat money laundering and terrorist financing. The USA Patriot Act requires all financial institutions to obtain, verify, and record information that identifies each person or entity that opens an account or establishes a relationship with the Firm. Specifically, EDGE is required to collect the following information: legal name, date of birth, address and identification number (TIN or SSN). A legal entity may need to provide other information such as its principal place of business, local office, employer identification number, certified articles of incorporation, government-issued business license, and a partnership agreement or a trust agreement. We may also ask for a copy of your driver’s license or seek additional documentation.

FINRA’s BrokerCheck

The Financial Industry Regulatory Authority runs a public disclosure program known as BrokerCheck that provides information about brokerage firms and their registered persons. To obtain an investor brochure that includes information about BrokerCheck or to obtain additional information, contact the FINRA public disclosure hotline at (800) 289-9999 or visit the BrokerCheck website at brokercheck.finra.org. FINRA’s website is located at finra.org.

Market Research

Market Research Report publications prepared by Edgemont Capital Partners, L.P., are for general informational and discussion purposes in connection with industry and mergers-and-acquisitions market developments. They are intended to provide general sector and transaction commentary and do not constitute investment research or a research report within the meaning of FINRA Rules 2241 or 2242. The publications are not prepared by a research department or research analyst and do not contain a recommendation, rating, or price target concerning any security.

Nothing in the publications constitutes investment, legal, tax, accounting, or other professional advice; a recommendation to buy, sell, or hold any security; or an offer to sell or solicitation of an offer to buy any security or participate in any transaction. Any transaction examples, valuation information, or market observations are illustrative, may not be comparable to a particular company or transaction, and should not be relied upon as the basis for an investment or transaction decision.

The views expressed reflect Edgemont’s observations regarding the particular healthcare sector or topic as of the date indicated, and are subject to change without notice. Any estimates, projections, or forward-looking statements are inherently uncertain, depend on assumptions, and may not be realized. Actual results may differ materially.

Information has been obtained from public and other sources believed to be reliable, but Edgemont has not independently verified all information and makes no representation or warranty, express or implied, as to its accuracy, completeness, or currency. Edgemont undertakes no obligation to update any publication. Recipients should conduct their own independent investigation and consult their professional advisers before making any business, transaction, or investment decision.

Edgemont and its affiliates may provide or seek to provide investment-banking, financial-advisory, or other services to companies discussed in this publication and may receive compensation for those services. Any company-specific relationship or other material conflict will be disclosed where required by applicable law, regulation, or firm policy.

© 2026 Edgemont Capital Partners, L.P. member FINRA/SIPC. All rights reserved. ECP Market Research publications may not be reproduced or redistributed, in whole or in part, without Edgemont’s prior written consent.